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Abstract
Background: Ricin is a potent toxin and known bioterrorism threat with no available antidote. The ricin
A-chain (RTA) acts enzymatically to cleave a specific adenine base from ribosomal RNA, thereby blocking
translation. To understand better the relationship between ligand binding and RTA active site
conformational change, we used a fragment-based approach to find a minimal set of bonding interactions
able to induce rearrangements in critical side-chain positions.
Results: We found that the smallest ligand stabilizing an open conformer of the RTA active site pocket
was an amide group, bound weakly by only a few hydrogen bonds to the protein. Complexes with small
amide-containing molecules also revealed a switch in geometry from a parallel towards a splayed
arrangement of an arginine-tryptophan cation-pi interaction that was associated with an increase and red-
shift in tryptophan fluorescence upon ligand binding. Using the observed fluorescence signal, we
determined the thermodynamic changes of adenine binding to the RTA active site, as well as the site-
specific binding of urea. Urea binding had a favorable enthalpy change and unfavorable entropy change, with
a ΔH of -13 ± 2 kJ/mol and a ΔS of -0.04 ± 0.01 kJ/(K*mol). The side-chain position of residue Tyr80 in a
complex with adenine was found not to involve as large an overlap of rings with the purine as previously
considered, suggesting a smaller role for aromatic stacking at the RTA active site.
Conclusion:  We found that amide ligands can bind weakly but specifically to the ricin active site,
producing significant shifts in positions of the critical active site residues Arg180 and Tyr80. These results
indicate that fragment-based drug discovery methods are capable of identifying minimal bonding
determinants of active-site side-chain rearrangements and the mechanistic origins of spectroscopic shifts.
Our results suggest that tryptophan fluorescence provides a sensitive probe for the geometric relationship
of arginine-tryptophan pairs, which often have significant roles in protein function. Using the unusual
characteristics of the RTA system, we measured the still controversial thermodynamic changes of site-
specific urea binding to a protein, results that are relevant to understanding the physical mechanisms of
protein denaturation.
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Background
Ricin toxin is a potent ribosome-inactivating protein
derived from the castor bean and a relatively common
bioterrorism agent [1]. The heterodimeric toxin consists
of a lectin B-chain linked by a disulfide bond to a catalytic
A-chain (RTA). Free RTA inside the cell can irreversibly
inactivate ribosomes by cleaving the glysosidic bond of a
specific adenine base in the sarcin/ricin domain of 28S
ribosomal RNA [2]. One molecule of this toxin in the
cytosol may suffice to kill a human cell [3]. Although
death from ricin intoxication can take up to 5 days, no
specific therapeutic measures are available for interven-
tion.
Examination of the structural properties and conforma-
tional changes of the enzyme's active site is necessary for
the discovery of effective inhibitors [4,5]. Induction of a
conformational change opening the RTA active site "spe-
cificity pocket" has been proposed to be an essential prop-
erty of an effective inhibitor [5]. We were therefore
interested in determining a minimal set of bonding inter-
actions able to stabilize an open conformer appropriate
for inhibitor binding, prompting an exploration of very
small RTA ligands.
Some purines can function as ricin inhibitors, including
adenine, the product of enzymatic cleavage [6]. The struc-
ture (1IFS) of recombinant ricin A-chain (RTA) in com-
plex with adenine at the active site [7] revealed that
tyrosine 80 had rotated out of its original position to open
the catalytic pocket, although the observed electron den-
sity for this residue was weak. Stacking of the purine with
tyrosine 80 was also observed with other aromatic inhibi-
tors [5,8,9]. We found that a few hydrogen bonds made by
an amide group were capable of promoting that confor-
mation; aromatic stacking was not essential. These results
suggest that a wider range of molecules, including peptide
derivatives, may be explored as components of ricin
inhibitors.
We found that the geometry of a cation-pi interaction
between the catalytically critical residue arginine 180 and
the single tryptophan 211 shifted from parallel towards
splayed in response to the presence of small amide-con-
taining ligands. An increase and red-shift in the intrinsic
protein fluorescence observed on ligand binding was very
similar both to that observed by Watanabe et al. [10] for
RTA-adenine, as well as that associated with another
arginine-tryptophan interaction in the protein Csk [11].
Fluorescence changes in RTA also provided a useful probe
for examination of the specificity and thermodynamics of
urea binding, a subject important for understanding the
mechanism of protein unfolding [12]. Although urea
denaturation is commonly used to determine the free
energy changes of protein folding, the physical forces and
mechanism underlying this phenomenon are not yet
entirely clear.
Results
Fluorescence changes induced by active site ligands
While studying the unfolding of RTA by urea, we observed
a pre-denaturational increase in fluorescence with increas-
ing urea concentration (Fig. 1). The hyperbolic shape of
the curve suggested a binding event, therefore we chose to
investigate whether urea could bind to RTA at a particular
site and influence protein fluorescence. RTA has a single
tryptophan, residue 211, located at the active site pocket.
Fig. 1 shows emission spectra from RTA in the presence of
2 mM adenine or 1.0 M urea, which have very similar
increases in intensity and red-shift from the spectra of RTA
alone. The wavelength of maximal emission in both cases
increased from 330 to 334 nm. This phenomenon is not
caused by urea-induced denaturation, which occurred at
higher concentrations as monitored by circular dichroism
or fluorescence (Fig. 1). Titration with guanidine-HCl also
did not produce a fluorescence increase [13,14].
We next tested a set of small amide-containing molecules
related to urea (Fig. 1), and found that at molar concen-
trations some also produced similar fluorescence
increases, including formamide, acetamide and N-methy-
lurea (NMU). In contrast, hydroxyurea, and N, N-dimeth-
ylurea did not. A structural explanation for this finding
will be provided below.
We hypothesized from these results that urea, formamide,
acetamide, and NMU can bind specifically to the RTA
active site at the same locus as adenine, also inducing a
conformational change resulting in an increase in fluores-
cence. Inspection of the structures of adenine-bound ver-
sus unbound RTA, solved by Weston et al. [7], suggested
that a specific H-bond accepted by N3 of adenine from
arginine 180 caused this side-chain to rotate away from a
co-planar arrangement with tryptophan 211. Such a
movement of the charged terminal guanidinium group of
arginine could alter the electronic environment of the
tryptophan, resulting in the observed fluorescence
increase. A similar interaction with arginine 180 might be
made either directly or indirectly by the carbonyl group of
a urea molecule bound at the same locus as adenine.
Unlike urea, guanidine-HCl is capable only of acting as a
donor and so could not form this H-bond, consistent with
its inability to produce a fluorescence increase.
Decrease of urea concentration by ten-fold dilution from
1.5 M showed that the fluorescence change was reversible,
whereas RTA denaturation was largely irreversible (not
shown). Near-UV CD spectra (not shown) of RTA in 1.5
M or 0 M urea both had a strong negative peak at 295 nm.
This indicated that tryptophan 211 was present in anBMC Structural Biology 2007, 7:72 http://www.biomedcentral.com/1472-6807/7/72
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Compound effects on RTA fluorescence and circular dichroism Figure 1
Compound effects on RTA fluorescence and circular dichroism. (A) Fluorescence emission (circles) and far-UV CD 
(triangles) changes on titration with urea. (B) Fluorescence spectra in PBS buffer alone (solid line), 1 M urea (dashed line) and 
2 mM adenine (dotted line). (C) Fluorescence in the presence of (a) 2 M formamide, (b) 1 M N-methylurea, (c) 1 M N, N-
dimethylurea, (d) buffer alone, and (e) 1 M hydroxyurea, in order of decreasing maximal intensity.BMC Structural Biology 2007, 7:72 http://www.biomedcentral.com/1472-6807/7/72
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asymmetric electronic environment in both cases, consist-
ent with preservation of local tertiary structure at the
active site. The UV absorbance spectrum of RTA also was
not affected by 1.5 M urea. The non-coincidence of dena-
turational processes observed by circular dichroism versus
fluorescence (Fig. 1) is due to the presence of an interme-
diate state in unfolding of RTA [14].
RTA-ligand complexes
To test for ligand binding, we soaked RTA crystals in solu-
tions of mother liquor containing 2 M NMU, 1 M urea, or
2 M acetamide. These concentrations were chosen to max-
imize ligand occupancy while avoiding protein denatura-
tion. The highest quality result was obtained with NMU.
This structure was refined to 1.8 Å resolution with an Rcryst
of 22.5% and an Rfree of 24.3% (Table 1). The electron
density for tyrosine 80 obtained by molecular replace-
ment phasing with the RTA structural model 1IFT indi-
cated that this residue had moved in the presence of NMU
(Fig. 2). Upon refining tyrosine 80 in an alternate confor-
mation at full occupancy, positive-difference electron
density consistent with an NMU molecule at the active site
became clear in 2mFo-DFc maps. We refined an NMU
molecule in this density as shown in Figure 2, along with
a proximal water molecule. The asymmetry and hydro-
gen-bonding potential of NMU supported placement of
the ligand with a unique orientation.
As in the RTA-adenine complex 1IFS [7], arginine 180
rotated out of plane with the stationary indole ring of
tryptophan 211 in the presence of NMU (Fig. 3), and to a
greater angle. In the complex with NMU, a single ligand
molecule was observed occupying the same position as
the adenine base, lying nearly in the same plane. No other
molecule of NMU was found. A water molecule (number
384) was positioned to donate an H-bond to the carbonyl
group of NMU, while simultaneously forming bidentate
H-bonds with the side-chain of arginine 180. This water
was associated with a strong electron density peak and a
B-factor of 20.7 Å2, suggesting that it was relatively tightly
bound. NMU also was positioned to form H-bonds with
the peptide backbone at residues valine 81 and glycine
121, comparable with those proposed for the adenine
complex. The refined structure of RTA in the N-methylu-
rea complex was overall very similar to that of unbound
RTA (1IFT) with a root-mean-square-deviation of 0.84 Å
for all protein atoms.
The rotameric position of Tyr80 shifted in the presence of
all the studied ligands (Fig. 3), allowing access to poten-
tial H-bond partners in the active site side-chains. How-
ever, we found that the position of Tyr80 in a newly
determined structure of RTA soaked in 2 mM adenine was
not the same as that previously reported ([7]). It may be 
Table 1: X-ray data collection and refinement statistics.
Data Collection RTA – NMU RTA – urea RTA – acetamide RTA- adenine
Space Group P 41212P  4 1212P  4 1212P  4 1212
Unit cell dimensions (Å)
A 67.73 67.37 67.11 68.16
B 67.73 67.37 67.11 68.16
C 140.77 141.14 141.32 141.20
Resolution range (Å)a 30–1.80 (1.91–1.80) 23–2.40 (2.55-2.40) 34–2.09 (2.22-2.09) 34–1.94 (2.06-1.94)
Rsym
a 0.064 (0.455) 0.114 (0.373) 0.093 (0.350) 0.128 (0.339)
Completeness (%) a 99.6 (99.9) 99.7 (99.8) 99.9 (99.8) 99.9 (99.9)
Redundancy 7.0 4.4 17.9 12.4
Unique reflections 31,106 13,295 19,857 26,260
I/σIa 34.0 (4.80) 8.9 (3.7) 7.09 (1.71) 17.8 (8.88)
Refinement
Total atoms 2,178 2,118 2,157 2,197
Protein atoms 2,038 2,038 2,037 2,037
Water atoms 125 66 106 134
Ligand atoms 5 4 4 10
Sulfate atoms 10 10 10 15
Rcryst
b 0.231 (0.252) 0.252 (0.286) 0.234 (0.252) 0.265 (0.270)
Rfree
b 0.247 (0.267) 0.297 (0.355) 0.272 (0.319) 0.301 (0.304)
R.m.s. deviations
Bond length (Å) 0.0050 0.0066 0.0075 0.011
Bond angle (°) 1.10 1.16 1.25 1.20
Mean temperature factor (Å2)
For all atoms 22 24 21 20
For ligand atoms 20 17 21 21
a Values in parentheses are for the highest resolution bin. b Rcryst = Σ|o – Fc|/Σ|Fo| for reflections in the working set, as calculated by CNS; Rfree is for 
a 5% test set of reflections excluded from crystallographic refinement.BMC Structural Biology 2007, 7:72 http://www.biomedcentral.com/1472-6807/7/72
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Electron density maps of the RTA-NMU complex instereo Figure 2
Electron density maps of the RTA-NMU complex ins-
tereo. (A) Initial 2mFo-DFc map before repositioning of 
Tyr80. Contoured at 1σ (blue), 2σ (purple), 3σ (pink), 4σ 
(magenta), and 5σ (red). (B) Density recalculated after 
removal of the Tyr80 ring. (C) After repositioning Tyr80 to 
fit the observed density and one round of refinement. (D) 
Density before placement of N-methylurea and water mole-
cules at the active site. (E) Final structure after placement of 
ligand and water.
Ligand effects on active site conformation Figure 3
Ligand effects on active site conformation. (A) RTA 
without bound ligand (1IFT [7]). Figure made in stereo with 
SPDBV [46] and POV-Ray. (B) RTA with bound adenine. The 
position of Tyr80 in structure 1IFS is shown in cyan, and in 
2P8N in yellow. (C) Closer view of the effect of binding ade-
nine on the active site. Tyr80 in structure 1IFT (without ade-
nine) is in green, 1IFS in cyan, and 2P8N in yellow. The 
2mFo-DFc electron density of Tyr80 in 2P8N is contoured at 
1.5σ. (D) RTA-NMU complex. A single water molecule is 
shown in light blue. (E) RTA-urea complex.BMC Structural Biology 2007, 7:72 http://www.biomedcentral.com/1472-6807/7/72
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important to note that the 1IFS RTA-adenine complex wa
prepared differently; pre-formed RTA crystals were soaked
with AMP, which apparently resulted in catalytic cleavage
of the glycosidic bond to yield an adenine bound in the
active site. The position of the Tyr80 in structure 1IFS was
relatively disordered, with a calculated occupancy of 0.6
for atoms in the ring and an average B-factor of 42 Å2 ver-
sus 27 Å2 for all atoms. In the RTA-adenine complex
2P8N, we observed strong positive difference electron
density at the 4σ level in omit maps calculated by exclud-
ing this residue, allowing an alternative position to be
determined as shown in Fig. 3. The average B-factor of ring
carbons for Tyr80 was 30 Å2 versus 21 Å2 in all atoms. The
electron densities of the ring and Cα-Cβ-Cγ bonds were
clear throughout refinement, indicating re-orientation of
the side-chain to the relatively common t80° rotamer
[15]. In this position, the hydroxyl group of Tyr80 can
hydrogen bond with the amide nitrogen of Gly121. The
positions of the adenine ligand and Arg180 in this struc-
ture were comparable to those observed in the 1IFS
model.
Movement of the charged guanidinium group of Arg180
relative to the tryptophan provides a clear structural expla-
nation for the increase and red-shift in fluorescence emis-
sion observed by our group and Watanabe et al. [10]. The
angle formed from the tryptophan 211 phenyl ring cen-
troid to NE and HE of arginine 180 changed from 87° in
RTA alone (1IFT) to 58° in the adenine complex (1IFS),
and 37° in the RTA-NMU complex.
The structures of RTA complexes with urea (Fig. 3) or
acetamide (not shown) were also solved. Urea was more
disruptive to the crystals than was NMU, but we were able
to collect a complete dataset on a crystal soaked in 1 M
urea diffracting to 2.4 Å. The angle adopted by the tyro-
sine 80 ring was more co-planar to the ligand in the pres-
ence of urea versus NMU, perhaps reflecting the absence
of steric interference with the ring from the methyl group
of NMU. A single water molecule was positioned to H-
bond with both the urea molecule and the side chain of
arginine 180. Acetamide, which lacks the second amino
nitrogen of urea and can make H-bonds only from an
amide group, yielded a similar structure.
Binding constants and energetics
Fluorescence emission provided a useful probe to deter-
mine binding constants and thermodynamic changes for
the compounds tested, including adenine (Table 2). Titra-
tion of the ligands onto RTA as monitored by fluorescence
intensity at 344 nm yielded hyperbolic curves (Fig. 4) that
could be well described by non-linear regression with a
model of single-site binding. The KD of urea for RTA at
25°C was 0.5 M (Table 2). Its affinity was temperature-
dependent, being stronger at lower temperature due to a
negative enthalpy change of binding. Formamide and
acetamide bound more weakly than urea, with KD values
of 0.9 and 1.4 M respectively, presumably due to their lack
of a second amino H-bond donor. A greater maximal flu-
orescence emission increase was observed at higher tem-
peratures, but this may be due more to the intrinsic
temperature dependence of indole fluorescence rather
than differences in molecular interactions with the pro-
tein.
In contrast, hydroxyurea at 1 M gave no detectable fluores-
cence increase (Fig 1c). The difference in behavior of
NMU versus hydroxyurea is explicable with reference to
the crystal structures. Modeling hydroxyurea onto the
NMU complex places it into an unfavorable environment
without adequate H-bonding partners for the hydroxyl
group. N, N-dimethylurea appeared to bind weakly if at
all in fluorescence experiments (Fig. 1), and a dissociation
constant could not be determined in that case. Steric inter-
ference with phenylalanine 93 by the second methyl
group of the ligand likely prevented binding in that case.
Watanabe et al. [10] found that binding of adenine to the
RTA depurination site as monitored by fluorescence had a
KD of 1 mM, in agreement with our figure of 0.7 ± 0.05
mM (Table 2). Those authors found a non-linear Scatch-
ard plot for adenine binding, suggesting the presence of
two sites of differing affinity. However, our data were well
described by a model of a single site (Fig. 4), using either
non-linear regression or Scatchard analysis (R = 0.98). A
ligand stoichiometry of one was justified by the crystallo-
graphic results showing one molecule of each ligand at the
active site. While it is possible that other ligand molecules
associated with the protein at other loci, no suitable elec-
tron density for other bound ligands was observed. More-
over, only the ligand bound as shown in Figure 3 has a
clear mechanism to influence the environment of the sole
indole ring fluorophore, by altering the position of
arginine 180. Ligand molecules in other areas of the pro-
tein would be spectroscopically silent if present.
To find the enthalpy and entropy changes associated with
binding of urea or adenine to RTA, titration experiments
Table 2: Energetics of ligands binding to RTA.
Compound KD (M)a ΔG° 
(kJ/mol)a
ΔH° 
(kJ/mol)
ΔS° (kJ/
(K*mol))
Urea 0.5 ± 0.09 -2 ± 0.6 -13 ± 2 -0.04 ± 0.01
N-methylurea 0.9 ± 0.04 -0.2 ± 0.09 --- ---
Acetamide 1.4 ± 0.03 0.8 ± 0.06 --- ---
Formamide 0.9 ± 0.1 0 ± 0.3 --- ---
Adenine (7 ± 0.5) × 10-4 -20 ± 0.6 -53 ± 3 -0.12 ± 0.01
a Results are the average and standard error of three measurements.BMC Structural Biology 2007, 7:72 http://www.biomedcentral.com/1472-6807/7/72
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were carried out over a temperature range from 5 to 30°C
(Fig. 5). The temperature range was limited to avoid
effects from irreversible unfolding of the protein. Van't
Hoff analysis gave a ΔH° for urea binding of -13 ± 2 kJ/
mol. The amount of scatter in the data was too large and
the temperature range too narrow to determine ΔCp by fit-
ting with a temperature-dependent enthalpy change.
However, the slight deviation from linearity of this plot (R
= 0.85) indicated that the ΔCp of binding must be rela-
tively small. An unfavorable entropy change of -0.04 ±
0.01 kJ/(K*mol) opposed the enthalpy change, resulting
in a ΔG° of -2 ± 0.6 kJ/mol. For the larger and tighter-
binding ligand adenine, ΔH° was -53 kJ/mol (R = 0.97)
with a ΔS° of -0.12 ± 0.01 kJ/(K*mol). NMU, acetamide,
and formamide gave complex non-linear results in van't
Hoff analysis that did not allow determination of ΔH and
ΔS, perhaps due to their lower affinities for the protein.
Discussion
Effects of changes in geometry of Arg180-Trp211
Arginine 180 of RTA plays a crucial role in catalysis, prob-
ably by protonation of the adenine leaving group
[8,16,17]. In the structure of RTA complexed with NMU
(Fig. 2 and 6), the ligand apparently made an H-bond to
a water molecule which was linked through bidentate H-
bonding to arginine 180. As a result, the relationship of
the arginine and tryptophan residues changed from a
"stacked" geometry towards a "splayed" one [18]. The dis-
tance of the NH1 atom of arginine 180 to the centroid of
the tryptophan 211 aromatic ring increased from 4.2 Å in
RTA alone to 5.5 Å in the RTA-NMU complex. By compar-
ison, in the RTA-adenine structure of Weston et al. this
distance was 5.1 Å.
The intensity increase and red-shift in fluorescence emis-
sion observed when Arg180 rotates away from Trp211
could be attributed to a release from quenching, as was
proposed by Watanabe et al. [10]. However, arginine is
not known to be a quencher of indole fluorescence [19].
Alternatively, specific interactions made to the tryptophan
by arginine in the splayed geometry could be responsible
van't Hoff plots Figure 5
van't Hoff plots. Temperature dependence of binding of 
urea (triangles) or adenine (circles) to RTA.
Binding isotherms Figure 4
Binding isotherms. (A) Fluorescence emission increase on 
titration of RTA with urea at 5°C (open circles) and 30°C 
(open triangles), and NMU at 5°C (filled circles) and 30°C 
(filled triangles). (B) Titration with adenine (diamonds) and 
formamide (squares) at 25°C. The axis for adenine is in milli-
molar (top). A Scatchard plot for adenine binding is inset.BMC Structural Biology 2007, 7:72 http://www.biomedcentral.com/1472-6807/7/72
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for an enhancement of fluorescence. A similar difference
in fluorescence emission has been observed with mutants
of the tyrosine kinase Csk. In the catalytic domain of Csk,
Arg318 makes a cation-pi interaction to Trp352, with the
terminal guanidinium perpendicular to the face of the
indole ring [20]. Using an alanine substitution of the
arginine, Lee et al. [11] showed that the presence of this
interaction was responsible for an approximately 35%
increase and 3 nm red-shift in tryptophan fluorescence,
very close to the difference in emission observed between
the two conformers of RTA. A red-shift in fluorescence
emission is normally attributed to an increase in environ-
mental polarity experienced by the tryptophan, often due
to greater solvation. However, in the case of RTA, the local
electronic environment and λmax appear to be significantly
affected by the proximity and angular relationship of the
indole ring to a charged side-chain.
Cation-pi interactions are known to participate in sub-
strate binding and enzyme catalysis [21], as well as key
structural interactions within and between protein subu-
nits [22,23]. Important functional roles are often played
by arginine residues paired with aromatics [24-26], fifty
percent of which are coplanar [22]. A correlation of fluo-
rescence spectral changes with shifts in this residue-pair-
ing geometry, if generalizable, may provide a useful tool
to examine structure-function relationships in other pro-
teins.
The Arg180-Trp211 cation-pi interaction also appears to
be important for stable folding of RTA. Substitution of
arginine 180 with neutral amino acids yielded unstable
proteins that precipitated during expression [16], while
R180H was stable only when the histidine was positively
charged at less than neutral pH [27]. Histidine replace-
ment of Arg180 decreased kcat by greater than a thousand-
fold. Replacement with lysine (R180K) reduced activity
only four times, consistent with a role for this residue in
donation of a proton to N3 of adenine [16,17].
Tyrosine 80 also changes position on ligand binding and
may be able to affect Trp211 fluorescence. However, we
find this less plausible because Tyr80 is relatively distant
from Trp211 compared to Arg180. The distance in the
RTA-adenine complex 2P8N from Trp211 CZ3 to Tyr80
CD2 was 7.5 Å, versus 3.9 Å to Arg180 CZ. The RTA-urea
and RTA-adenine complexes also showed similar fluores-
cence spectra (Fig. 1) and a splayed arrangement of
Arg180, while the positions of Tyr80 in these complexes
differed (Fig. 3). The orientation of Tyr80 did not there-
fore appear to control the fluorescence emission of
Trp211.
Thermodynamic changes of urea binding
The fortuitous existence in RTA of a conformational
switch triggered by ligand binding provided a convenient
signal for monitoring the binding of urea and other lig-
ands. We were thereby able to determine for the first time
the thermodynamic changes associated with binding of a
single urea molecule to a protein. Although the binding
observed was weak, it was specific to the depurination
locus, as evidenced by the RTA-urea complex structure.
The energies of urea-protein interactions are relevant to
understanding of the mechanism of denaturation by urea;
a fundamental issue in protein folding that remains under
discussion. Models proposed for this mechanism include
those based on specific binding of urea molecules, indi-
rect effects on solvent structure and protein hydrophobic-
ity, and competition for H-bonding with the protein
backbone [28]. Because urea is a commonly used chemi-
cal scaffold, drug design approaches that utilize thermo-
dynamic information for ligand optimization may also
benefit from basic data on the enthalpy and entropy
changes of urea binding [29].
In this analysis, we employed a simple binding isotherm
instead of the solvent exchange model of Schellman [30]
often used for the analysis of preferential hydration when
denaturant molecules and water compete for a weak bind-
ing site on a protein [31]. On the basis of the determined
structures, the binding of amide ligands to the RTA active
Geometry of the arginine 180 – tryptophan 211 interaction Figure 6
Geometry of the arginine 180 – tryptophan 211 inter-
action. The structure of RTA without a ligand (1IFT [7]) is in 
yellow, overlaid on the RTA-NMU complex in purple. Dis-
tances from the ring centroid to arginine 180 NH1 in the 
RTA-NMU complex are indicated.BMC Structural Biology 2007, 7:72 http://www.biomedcentral.com/1472-6807/7/72
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site is to a locus previously occupied by a protein side-
chain (Fig. 2), not water, therefore the use of a solvent
exchange model did not appear to be justified in this case.
The value of -13 ± 2 kJ/mol we obtained for the ΔH° of
urea binding by van't Hoff analysis can be compared to
that of Makhatadze and Privalov [32], who arrived at a fig-
ure of -9 kJ/mol for general protein-urea interactions
using a combination of flow-mixing and scanning calor-
imetry. In contrast, Zou et al. [33] gave a value of -34 kJ/
mol for urea-amide interactions obtained by dissolution
of cyclic dipeptides into urea solutions. In comparing
these values, it should be kept in mind that the ΔH° we
measured for urea binding to RTA was for one specific site,
not an average over many different interactions. It also
necessarily includes the enthalpy change associated with
the shift of side-chain positions at the active site, although
this is likely to be small. The extent to which these ther-
modynamic results for urea binding can be generalized to
other loci is as yet unclear, due to a paucity of other data
on site-specific binding. However, Gill et al. [34] reported
a ΔH° value of -14.2 ± 2.1 kJ/mol for urea binding to the
peptide model diketopiperazine. This is the same as our
figure within error, suggesting that the ΔH° value we have
determined is consistent with urea/peptide interactions in
general.
An increase in fluorescence of RNase T1 in the early phase
of a guanidine-HCl denaturation experiment has also
been observed [35] and attributed to specific binding of a
guanidine cation to the folded state. As Pace et al. con-
cluded, adequately strong and specific binding of a denat-
urant molecule can significantly affect the shape of a
denaturation transition curve, producing non-linearity in
plots of ΔG as a function of denaturant concentration and
discrepancies in m  values. The irreversibility of RTA
unfolding precludes that analysis in this case. Few other
examples exist in the literature of discrete protein binding
sites identified for urea. This is at least partly due to the
difficulty of measurement and detection of interactions
with very weak affinities. Urea at 8 M concentration was
observed to bind to lysozyme at nine loci, including the
"acetamido-specific" C subsite [36,37]. However, the
binding constants for these interactions are not known. At
8 M urea, solvent reorganization results in a weakening of
the hydrophobic effect [12]. However, up to 1 M urea,
changes in solvent structure as predicted by molecular
dynamics are small [28], allowing the thermodynamic
changes we measured to be attributed directly to binding
of urea to the RTA active site.
Implications for RTA inhibitor design
Investigation of small-molecule inhibitors of ricin has so
far mainly focused on nucleotide and RNA substrate ana-
logs [38]. The strongest inhibitors reported in the litera-
ture to date are nanomolar-range Ki  molecules
incorporating a pyrrolidine transition-state analog moiety
into an RNA stem-loop structure [39]. Miller et al. [5] pro-
posed that opening of the RTA active site's "specificity
pocket" by displacement of the tyrosine 80 ring is an
important characteristic for a good inhibitor. Identifica-
tion of the necessary bonding interactions promoting this
shift is therefore significant for the discovery of therapeu-
tic compounds. Earlier structures of complexes of RTA
with adenine and other inhibitory compounds including
formycin monophosphate and pteroic acid revealed their
aromatic rings stacking with tyrosine 80 in its "open" or
displaced position [7-9]. Upon examination of a crystal
complex of RTA with adenine formed by soaking with
adenine instead of AMP, we found that the overlap of the
tyrosine 80 ring with the purine was much less than pre-
viously reported, due to a difference in side-chain rota-
meric position.
The alternative orientation of Tyr80 in the adenine-bound
complex 2P8N compared with that observed in 1IFS sug-
gests that the contribution of stacking to ligand binding is
small, or that offset stacking is more favorable than direct
overlap. Therefore it may be possible to identify other
classes of inhibitors that do not rely on aromaticity to
bind this pocket, although purines and their derivatives
clearly have the greatest affinity of compounds examined
to date. A possible H-bond of the Tyr80 hydroxyl with the
Gly121 backbone may also favor the position shown in
2P8N. Displacement of Tyr80 was also observed in the
RTA-NMU and RTA-urea complex structures (Fig. 3),
although the resulting side-chain position was not identi-
cal. The apparent difference in Tyr80 Chi2 angles between
the RTA-NMU and RTA-urea complexes may reflect steric
constraints imposed by the methyl group of NMU.
Conclusion
Using a "fragment-based" approach [40] combining spec-
troscopic and crystal structure data on the ricin A-chain,
we identified a minimal set of ligand interactions able to
produce positional shifts of the critical active-site residues
arginine 180 and tyrosine 80. Hydrogen bonds made by
an amide group alone were sufficient to produce a confor-
mational change at the active site pocket, while aromatic
stacking of the ligand with tyrosine 80 was not absolutely
necessary. The range of useful compounds for construc-
tion of ricin inhibitors may, therefore, be larger than pre-
viously anticipated. We also propose a plausible
mechanistic explanation for the origin of a shift in tryp-
tophan fluorescence emission involving a change in
geometry of a cation-pi interaction. Using the spectral
characteristics of the RTA system, we measured the ther-
modynamic changes of site-specific binding of urea to a
protein, results that bear on models of the mechanism of
urea-induced denaturation.BMC Structural Biology 2007, 7:72 http://www.biomedcentral.com/1472-6807/7/72
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Methods
Spectroscopic experiments
RTA was expressed in E. coli and purified by ion exchange
chromatography. Circular dichroism and dynamic light
scattering measurements showed that the protein was an
appropriately folded, monodisperse monomer. Titration
experiments were carried out using a Peltier-controlled
Jasco J-810 spectropolarimeter with a fluorescence attach-
ment. PBS buffer at pH 7.4 was used, except in the case of
adenine, where it was necessary to use 100 mM Na-Phos-
phate, pH 7.4, 0.1 mM dithiothreitol to prevent pH shifts
and protein oxidation upon adenine addition. Solutions
were made within 1 day of use, and formamide was thor-
oughly deionized with AG501-X8 resin (Bio-Rad). Con-
centrated ligand solutions were titrated into 0.1 mg/mL
protein solutions while tryptophan fluorescence was
excited at 295 nm and emission monitored. Emission at
344 nm (3 nm bandwidth) was chosen to maximize the
observable signal change. Isotherms were fit to the equa-
tion:
where Θ is the fractional saturation with ligand, K is the
binding constant, and [L] is the ligand concentration. For
urea and NMU, data to 1 M concentration were used in fit-
ting to avoid effects associated with irreversible denatura-
tion at higher concentrations. For the non-denaturing
compounds acetamide and formamide, data to 1.5 M
were used. Temperature was varied over the range of 5°C
to 30°C to determine the temperature dependence of K.
ΔH° and ΔS° were then found using the van't Hoff equa-
tion:
Crystallization and X-ray data collection
Tetragonal crystals of RTA were obtained at 22°C by vapor
diffusion in hanging drops [7]. Crystals were harvested
and soaked in artificial mother liquor (1.8 M ammonium
sulfate, 50 mM sodium acetate, pH 4.2) containing the
ligand molecule for 48 hours before transfer to paratone-
N oil and flash-cooling in liquid nitrogen. Ligand concen-
trations used were 2 M NMU, 1 M urea, and 2 M aceta-
mide. For the acetamide-RTA structure, data were
collected at 100 K on a Bruker FR591 high flux, rotating
anode X-ray diffractometer (PROTEUM) with a SMART
6000 2K CCD detector at WRAIR. For the adenine, NMU
and urea complexes, data were collected at 100 K on
beamlines X29 and X12C at the National Synchrotron
Light Source, Brookhaven National Laboratory.
Structures were solved by molecular replacement in space
group P41212 using AMoRe (CCP4) with the coordinates
of PDB entry 1IFT as a search model. Initial inappropriate
placement of the side chain of Tyr80 was evident in mFo –
DFc difference maps created with XtalView [41]. The Tyr80
ring therefore was removed by substitution with alanine,
and the model subjected to a round of refinement with
simulated annealing in CNS [42]. Recalculation of phases
revealed electron density extending from the backbone
towards a new position for the Tyr80 side-chain. Positive
difference electron density in mFo – DFc maps contoured
at 3 sigma then revealed the location of the ligand in the
RTA active site cleft. Amide-containing ligand molecules
were built and energy minimized with Insight II, then
positioned manually in the electron density at the active
site. Manual model rebuilding was done using σA-
weighted 2mFo  –  DFc  and mFo  –  DFc  maps [43] in
XtalView after successive rounds of crystallographic
refinement with the ligand. Water molecules were added
automatically to 3 sigma peaks in XtalView, and then eval-
uated individually. Sulfate molecules were added to
strong tetrahedral peaks of electron density on the surface
of the protein. The final refined model was evaluated
using PROCHECK [44] and found to have good geometry.
Molprobity [45] was used for model validation by an all-
atom contact analysis and to guide optimization of side-
chain rotamers. The coordinates and structure factors for
RTA-NMU (2PJO), RTA-urea (2R2X), and RTA-acetamide
(2R3D), and RTA-adenine (2P8N) have been deposited in
the Protein Data Bank.
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